Skyrizi
Eli Lilly launches Omvoh for ulcerative colitis after FDA nod
Eli Lilly, known for its weight loss contender Mounjaro, is making strides in the immunology arena. The FDA has granted ...
AbbVie’s Skyrizi beats J&J’s Stelara in head-to-head Crohn’s disease trial
AbbVie’s Skyrizi has notched a resounding victory over Johnson & Johnson’s biologic drug Stelara in treating Crohn’s disease, as revealed ...
AbbVie’s Skyrizi beats J&J’s Stelara in Crohn’s disease showdown
AbbVie’s revolutionary anti-inflammatory medication, Skyrizi, has been consistently outperforming its competitors in recent clinical trials, making waves in the field ...
How Skyrizi Outspent Other Drugs in a Tough Market
In July, AbbVie’s Skyrizi maintained its position as the top pharma drug ad spender for the second consecutive month, but ...
Skyrizi Beats Placebo in Psoriasis Phase 4 Study
Source – Abbvie On July 26, 2023 AbbVie announced the publication of results from the Phase IV IMMpulse study in ...